NICE Ltd ADRNICE
Price$116.48Intrinsic value$394.59239% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.9B+7.7% YoYTTM through 31 Dec 2025
Net Income $612.1M+39.3% YoYTTM through 31 Dec 2025
Free Cash Flow $697.6MTTM through 31 Dec 2025

Margins

Current
Gross Margin64.4%
EBITDA Margin28.7%
Operating Margin16.5%
Net Margin20.8%

Returns

16.4%ROE
10.8%ROA
17.5%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.55x
Net Debt-$304.1Mnet cash position
Cash & Equivalents$379.4M

Quality Metrics

Altman Z-Score5.40
Piotroski F-Score6 / 9
FCF Margin23.7%
Rule of 4031.7
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.9B
Diluted EPS$9.67TTM
'19'20'21'22'23'24'25
FY2025: $9.67

Dividend

$0.16Per share, FY20170.00%Yield

Capital Allocation

R&D Spend$360.5M
Capex Intensity0.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.